Fuentes RN, Loureiro RJL, Quintanal CNE, de Arriba RMU, Rodríguez PNJ, de la Paz RM

Idioma: Español
Referencias bibliográficas: 33
Paginas: 145-155
Archivo PDF: 1185.80 Kb.

RESUMEN

Objetivo: Analizar la presentación y evolución de 26 pacientes adultos con ependimoma espinal que recibieron tratamiento microquirúrgico en el Instituto de Neurología y Neurocirugía (La Habana, Cuba).
Métodos: Se estudió una serie de 26 pacientes con diagnóstico de ependimoma espinal sometidos a tratamiento con métodos microquirúrgicos. Se analizaron las manifestaciones clínicas, tiempo transcurrido antes del diagnóstico, características encontradas en los estudios de neuro–imágenes, tipo y grado de resección quirúrgica realizada, resultados postoperatorios logrados y factores pronósticos.
Resultados: Las edades de los pacientes oscilaron entre 30 y 65 años, con un 61,5 % entre 41–50 años. Los trastornos de la sensibilidad fueron los primeros síntomas y los más persistentes al ingreso en 21 pacientes (80,7 %). Predominaron los ependimomas espinales localizados en la región del filum terminale, cono y cauda equina. Se logró la extirpación radical del tumor en 22 pacientes. Hubo solamente dos pacientes con recurrencia tumoral que respondieron a la radioterapia. Se alcanzó una capacidad funcional neurológica en grado 1 de la escala de McCormick en más del 80 % de la serie (20 pacientes).
Conclusiones: El diagnóstico temprano y la cirugía radical de la tumoración son factores determinantes para una mínima o nula morbilidad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Villano JL, Parker CK, Dolecek TA. Descriptive epidemiology of ependymal tumours in the United States. Br J Cancer. 2013;108(11):2367–71.

2. Miller DC. Surgical pathology of intramedullary spinal cord neoplasms. J. Neurooncol. 2000;47:189–94.

3. Tarapore PE, Naujokas A, Amin B, Tihan T, Parsa AT, Ames CP, et al. Pathology of spinal ependymomas: An institutional experience over 25 years in 134 patients. Neurosurgery. 2013 May 10. [Epub ahead of print]

4. Chandy MJ, Babu S. Management of intramedullary spinal cord tumours: review of 68 patients. Neurol India. 2004;47:224–28.

5. Ogden AT, Wetjen N, Francavilla JL. Intramedullary spinal cord tumours. [Internet]. [citado 24.10.2008]. Disponible en: http://emedicine.medscape.com/article/251133– overview

6. Greenwood J. Intramedullary tumours of the spinal cord. A follow–up study after total surgical removal. J Neurosurgery. 1963;20:665.

7. Greenwood J. Surgical removal of intramedullary tumours. J Neurosurgery. 1967;26:276–82.

8. McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurgery. 1990;72(4):523–32.

9. Benzagmout M, Boujraf S, Oulali N, Chbani L, Amarti A, Chakour K, et al. Intradural extramedullary ependymoma: is there constantly a hormonal relationship?. Surg Neurol. 2008;70(5):536–38.

10. Kinsman MJ, Callahan JD, Hattab EM, Cohen–Gadol AA. Extramedullary spinal ependymoma: a diagnostic challenge and review of the literature. Clin Neurol Neurosurg. 2011;113:661–4.

11. Bonfield ChM, Amin D, Hamilton RL, Gerszten PC. Extramedullary ependymoma near the conus medullaris with lumbar nerve root attachment: Case report. Neurosurgery. 2011;68:831–4.

12. Ebert C, von Haken M, Meyer–Puttitz B, et al. Molecular genetic analysis of ependymal tumours. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol. 1999;155:627–32.

13. Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependimomas. A clinic pathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–93.

14. Radhakrishnan N, Nair NS, et al. Tanycytic ependymoma of filum terminale: A case report. Clin Neurol Neurosurg. 2012;114:169–71.

15. Shamji MF, Benoit BG, Perry AM, Jansen GH. Giant cell ependymoma of the thoracic spine: Pathology case report. J Neurosurgery. 2009;64(3):566–67.

16. Adamek D, Dec M, Sobol G, Urbanowicz B, Jaworski M. Giant cell ependymoma: A case report. Clin Neurol Neurosurg. 2008;110:176–81.

17. Akutsu H, Shibada Y, Okazaki M, Hyodo A, Matsumura A. Intramedullary clear cell ependymoma in the cervical spinal cord: A case report. Neurosurgery. 2000; 47(6):1434–39.

18. Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO classification of tumours of the Central Nervous System. 4th ed. Lyon: IARC Press; 2007. p. 72–78.

19. Oh MC, Kim JM, Kaur G, Safaee M, Sun MZ, et al. Prognosis by tumor location in adults with spinal ependymomas. Spine. 2012;12:591.

20. Schwartz TH, McCormick PC. Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol. 2000; 47(3):211– 18.

21. Patrona A, Harders A, Schmieder K, Scholz M. Intraventricular bleeding and transient hydrocephalus in a patient with hemorrhagic filum terminale ependymoma undergoing anticoagulation therapy with fherprocouman. Clin Neurol Neurosurg. 2010;112:552–57.

22. Voulgaris S, Alexiou GA, Zigouris A, Fotakopoulos G, Michos E, et al. Spinal ependymomas: prognostic factors and treatment results. J Neurosurg Spine. 2013; 18(3):226–35.

23. Waldron JJ, Cha S. Radiographic features of intramedullary spinal cord tumours. Neurosurg Clin N Am. 2006;17(1):13–9.

24. Fuentes RN, Felipe AM, Quintanal NC, Rodríguez NJP, et al. Ependimoma intradural extramedular primario. Rev Cub Med Mil. [revista en la Internet]. 2004 [citado 28.06.2013];33(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S013 8–65572004000100009&lng=es.

25. Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, Part 1: Intramedullary ependymomas. Neurosurgery. 2011;68(ONS suppl 1):ons57–ons63.

26. Kucia EJ, Manghan PH, Kakarla UK, Bambakidis NC, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, Part 2: Myxopapillary ependymoma. Neurosurgery. 2011;68(ONS 1):ons90–ons94.

27. Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, et al. Long–term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. J Cancer Res Ther. 2013;9(1):60–3.

28. Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, et al. Long–term outcome after resection of intraspinal ependymomas: Report of 86 consecutive cases. Neurosurgery. 2010;67(6):1622–31.

29. Wahab SH, Simpson JR, Michalski JM, Mansur DB. Long term outcome with post–operative radiation therapy for spinal canal ependymoma. J. Neurooncol. 2007;83(1):85– 9.

30. Fernandes AJ, Dos Santos MJ, Tedeshi H. Surgical management of intramedullary spinal ependymomas. Arq Neuropsiquiatr. 2009;67(2–A):284–9.

31. Bagley CA, Wilson S, Kothbaver KF, Bookland MS, Epstein F, Jallo GL. Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev. 2009;32(3):321–4.

32. Boström A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Boström JP, et al. Surgery for spinal cord ependymomas: Outcome and prognostic factors. Neurosurgery. 2011;63:302–9.

33. Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, et al. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: A single–center experience with 102 patients. Neurosurgery. 2011;68:188–97.